Written by Klarity Editorial Team
Published: Aug 21, 2026

Last updated: August 21, 2026
Zyprexa (olanzapine) is a second-generation (atypical) antipsychotic used for schizophrenia, bipolar I manic or mixed episodes, maintenance treatment of bipolar I disorder, and, when combined with fluoxetine, depressive episodes of bipolar I disorder and treatment-resistant depression. Brand oral tablets and Zyprexa Zydis orally disintegrating tablets come in several strengths (commonly 2.5 mg through 20 mg). Many people take oral olanzapine once daily with or without food. Short-acting intramuscular injection is labeled for acute agitation in schizophrenia or bipolar I mania in clinic or hospital settings. Long-acting olanzapine pamoate (Zyprexa Relprevv) is a separate injectable product with special monitoring rules. This guide covers how olanzapine works, typical label dosing ranges, metabolic and other side effects, boxed warnings, drug interactions, and when online psychiatry may be enough for evaluation and follow-up.
See if online depression or mood care may be a fit →
Browse Klarity condition pages →
Olanzapine is an atypical antipsychotic. According to MedlinePlus (last revised November 15, 2025), it is prescribed for schizophrenia and bipolar I disorder. It changes the activity of certain natural substances in the brain. MedlinePlus also notes that clinicians sometimes use olanzapine for other purposes (for example, chemotherapy-related nausea and vomiting); those uses are separate from the core psychiatric labels and need a clear clinical plan.
NAMI describes olanzapine as a second-generation antipsychotic (SGA) that rebalances dopamine and serotonin to improve thinking, mood, and behavior. NAMI lists oral tablets and orally disintegrating tablets, short-acting intramuscular injection, and the long-acting injectable Relprevv form. Brand names include Zyprexa and Zyprexa Zydis. Generic olanzapine tablets are widely available. Whether brand or generic is preferred depends on your plan’s formulary, not on a single clinic preference alone.
Common oral strengths discussed in patient education include 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, and 20 mg tablets or ODT products. Always match the strength and form on your prescription bottle.
Olanzapine blocks several neurotransmitter receptors, including dopamine D2 and serotonin 5-HT2A pathways that are central to psychosis and mania treatment (mechanism summarized on the DailyMed Zyprexa / olanzapine label). Clinically, that profile can reduce hallucinations, delusions, and severe mood elevation. It does not make the medicine free of risk. Olanzapine still carries the class warnings of atypical antipsychotics and needs medical supervision, lab and weight monitoring when indicated, and a plan for side effects.
MedlinePlus notes that olanzapine may help control symptoms but does not cure the underlying condition, and it may take several weeks or longer before you feel the full benefit. Do not stop suddenly without a plan from your prescriber.
NAMI’s timeline for antipsychotics is a useful expectation-setting tool: hallucinations, disorganized thinking, and delusions may improve in the first 1-2 weeks; motivation and social drive can take at least 1-2 weeks; full benefit may take 2-3 months. Your own course can be faster or slower.
Per the DailyMed prescribing information, oral olanzapine is indicated for:
DailyMed is explicit: olanzapine monotherapy is not indicated for depressive episodes of bipolar I disorder or for treatment-resistant depression. Those uses require the combination regimen (often discussed with Symbyax/olanzapine-fluoxetine or separate olanzapine plus fluoxetine under clinician direction).
Medication therapy for pediatric schizophrenia or bipolar I should follow a thorough diagnostic evaluation and careful risk–benefit discussion (label section 1.3).
Always follow the dose on your prescription. DailyMed highlights include these oral ranges:
Lower starting doses are recommended for debilitated or pharmacodynamically sensitive patients, people predisposed to hypotension, or those with slowed metabolism (label dosing notes).
MedlinePlus instructions for oral products:
NAMI notes that oral doses commonly fall in a range around 5-20 mg once daily, with slow increases over days to weeks. Only your clinician can set the correct dose for you.
Short-acting intramuscular olanzapine is labeled for acute agitation associated with schizophrenia and bipolar I mania in adults (DailyMed often cites 10 mg IM, with 5 mg or 7.5 mg when clinically warranted). That is a supervised medical setting, not a home self-injection routine.
Zyprexa Relprevv (olanzapine pamoate) is a long-acting injectable with a boxed warning and REMS-related post-injection observation requirements because of the risk of post-injection delirium/sedation syndrome. Relprevv decisions belong in specialty clinics set up for that product. Telehealth follow-up may still help for oral maintenance after acute care, but Relprevv itself is not a typical “mail-order shot at home” pathway.
Olanzapine levels can change with other medicines and with smoking. Clinicians often watch for:
MedlinePlus flags that some nonprescription products (certain allergy medicines; omeprazole) may interact and should be reviewed with a pharmacist or prescriber before you start or stop them. Bring a full medication and supplement list to every visit.
NAMI lists common effects such as drowsiness, dry mouth, constipation, dizziness, restlessness, and increased appetite. DailyMed highlights common adverse reactions that occurred at least twice as often as placebo in trials, including (by population):
Metabolic changes are a major class theme for olanzapine. DailyMed warns about hyperglycemia, dyslipidemia, and weight gain. Patients should receive regular weight monitoring and appropriate lab checks (for example, fasting lipids and glucose/A1c as directed). Adolescents can be especially sensitive to weight and appetite changes; the label calls out increased potential risk in that age group for some outcomes.
Serious risks that need urgent care include signs of neuroleptic malignant syndrome (high fever, stiff muscles, confusion, autonomic instability), severe allergic reactions or DRESS (rash with fever, swollen glands, organ involvement), uncontrolled movements (tardive dyskinesia), severe dizziness or falls, trouble swallowing, seizures, and symptoms of high blood sugar (extreme thirst, frequent urination, fruity breath, confusion).
MedlinePlus also notes orthostatic dizziness (rise slowly from lying down), heat intolerance (harder to cool down in extreme heat or heavy exercise), and possible effects on prolactin and menstrual or sexual function. Tell your clinician about thoughts of self-harm right away. If you or someone else is in crisis, call or text 988 (U.S. Suicide & Crisis Lifeline) or use local emergency services.
Like other antipsychotics, olanzapine carries a boxed warning: elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Olanzapine is not approved for dementia-related psychosis. MedlinePlus also notes a greater chance of stroke or mini-stroke in older adults with dementia treated with antipsychotics.
When olanzapine is used with fluoxetine for depression-related indications, antidepressant-class suicidality warnings for younger people apply. Read the Medication Guide that comes with each fill.
Discuss heart disease, low white blood cell counts, liver disease, seizures, glaucoma or other eye pressure concerns, prostate or urinary retention issues, bowel obstruction history, diabetes or high lipids, pregnancy and breastfeeding plans, and substance use history before starting. Third-trimester antipsychotic exposure can be linked to EPS or withdrawal symptoms in newborns; breastfeeding decisions need individualized counseling (NAMI and MedlinePlus both urge clinician discussion).
Olanzapine is not a controlled substance under federal scheduling the way stimulants are. That usually makes telehealth prescribing of non-controlled antipsychotics more straightforward than Schedule II stimulants, subject to state licensing, medical board rules, and clinical judgment. Many people use video visits for:
Telehealth is a weaker fit when you need emergency care for acute agitation, when Relprevv injection logistics apply, when severe medical instability is present, or when labs and in-person exams are overdue. Your clinician may still require labs, ECGs when indicated, or in-person evaluation.
Per HHS telehealth policy updates (page updated February 5, 2026), Medicare patients can permanently receive behavioral/mental health telehealth services in the home, without geographic originating-site restrictions, and behavioral telehealth may permanently use audio-only in qualifying situations. A separate temporary policy notes that the usual Medicare in-person visit within six months of an initial behavioral telehealth service (and annually thereafter) is not required through December 31, 2027. Commercial and Medicaid rules differ by plan and state.
Klarity Health connects people with 2,000+ licensed providers for online mental health and related care. A visit is an evaluation: a provider decides whether olanzapine or another medicine is appropriate, whether labs or referral are needed, and what follow-up looks like. No article can promise a prescription.
Check if online mood or depression care may work for you →
Coverage for brand Zyprexa, generic olanzapine, or olanzapine-fluoxetine combinations may vary by plan. Many formularies place generic olanzapine on a lower tier than brand Zyprexa. Prior authorization, step therapy, quantity limits, and specialty pharmacy rules are common for some formulations. Klarity does not control your insurer’s formulary. Verify benefits with your plan or pharmacy benefits manager before you assume a copay.
Disclaimer: This article is educational and is not medical advice, a diagnosis, or a guarantee of insurance coverage or prescribing. Coverage and clinical eligibility vary by plan, state, and individual history. Always verify benefits and follow your licensed clinician’s instructions. If you are in crisis, call or text 988 or seek emergency care.
People often compare olanzapine with other second-generation options already covered on Klarity’s site:
Olanzapine is often discussed for strong efficacy in psychosis and mania, with a tradeoff of higher metabolic risk for many patients compared with some peers. Latuda requires food for absorption; Geodon (ziprasidone) has important QT-related contraindications; aripiprazole and cariprazine have different activation and akathisia profiles. Choice is individualized.
Zyprexa is a brand name for olanzapine. Generic olanzapine contains the same active ingredient when manufactured to FDA standards. Inactive ingredients and appearance can differ.
Weight gain and increased appetite are well-documented risks. DailyMed requires clinicians and patients to consider the consequences of weight gain and to monitor weight regularly. Lifestyle support and, when appropriate, medication changes are clinical decisions.
Many licensed telehealth clinicians can evaluate and, when appropriate, prescribe non-controlled antipsychotics including olanzapine, subject to state law and medical necessity. No service can guarantee a prescription before a visit.
Some psychotic symptoms may ease within 1-2 weeks; fuller benefit often takes weeks to a few months (NAMI/MedlinePlus framing). Stay in contact with your prescriber during titration.
MedlinePlus: take the missed dose when you remember unless it is almost time for the next dose; do not double up. Confirm the plan with your own clinician if you miss doses often.
Zyprexa (olanzapine) is a widely used atypical antipsychotic for schizophrenia and bipolar I mania/mixed episodes, with combination-with-fluoxetine pathways for bipolar depression and treatment-resistant depression. It is taken once daily by mouth for most oral regimens, has meaningful metabolic monitoring needs, and carries dementia-related psychosis mortality warnings. Telehealth can be a practical way to start or continue oral psychiatric care when clinically appropriate, especially as Medicare behavioral telehealth-from-home rules remain favorable. For personalized care with Klarity’s network of 2,000+ providers, start with a condition or service page and complete an evaluation.
Explore online depression treatment options →
Sources: MedlinePlus olanzapine; NAMI olanzapine (Zyprexa); DailyMed Zyprexa/olanzapine; HHS telehealth policy updates.
Find the right provider for your needs — select your state to find expert care near you.